EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR ‐378a‐3p/ VEGFA / RGC ‐32 Axis

Jinli He, Yixing Luo, Ying Ding, Liang Zhu iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.70446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Jinli He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: MicroRNAs, Pancreatic Neoplasms, Vascular Endothelial Growth Factor A, Metformin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, project of Jiangxi Provincial Department of Science and Technology, the project of Jiangxi Provincial Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic cancer (PC) is a major contributor to global cancer‐related mortality. While the inhibitory effect of metformin (Met) on PC has been reported, the underlying mechanism remains elusive.

Methods

We established BxPC‐3 cell models with miR‐378a‐3p and VEGFA knockdown. The expression of miR‐378a‐3p, VEGFA, and RGC‐32 in PC and normal tissues was analyzed using GEPIA, TCGA databases. Cell proliferation, invasion, migration, and apoptosis were assessed through CCK8, Transwell, wound healing, and flow cytometry.

Results

Significantly lower expression of miR‐378a‐3p was observed in PC tissues and cells. Knockdown of miR‐378a‐3p reversed the impact of Met on cell viability in PANC‐1 and BxPC3. VEGFA emerged as a potential regulator in PC and a downstream target of miR‐378a‐3p. The interaction between VEGFA and RGC‐32 played a crucial role in PC regulation. Knockdown of VEGFA substantially reversed the impact of miR‐378a‐3p inhibitor on tumor growth and the epithelial‐mesenchymal transition (EMT) process. Moreover, knockdown of VEGFA effectively countered the influence of miR‐378a‐3p inhibitor on cell viability and the EMT process in BxPC3 cells.

Conclusions

Met exerted inhibitory effects on PC through the miR‐378a‐3p/VEGFA/RGC‐32 pathway. Strategies targeting the miR‐378a‐3p/VEGFA/RGC‐32 axis represent a novel avenue for the prevention and treatment of PC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsPancreatic NeoplasmsVascular Endothelial Growth Factor AMetforminCell ProliferationGene Expression Regulation, NeoplasticHumansCell Line, TumorAnimalsMiceCell MovementEpithelial-Mesenchymal TransitionApoptosisDisease ProgressionNerve Tissue ProteinsXenograft Model Antitumor AssaysMaleFemaleMuscle ProteinsGene Knockdown Techniques

Stichwörter der Autor:innen

MetVEGFAmiR‐378a‐3ppancreatic cancer

Substanzen

MicroRNAsMIRN378 microRNA, humanVascular Endothelial Growth Factor AMetforminVEGFA protein, humanNerve Tissue ProteinsMuscle Proteins

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Department of Medical Cosmetology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.

ORCID-Profile: Liang Zhu

Förderung

  • National Natural Science Foundation of China
  • project of Jiangxi Provincial Department of Science and Technology
  • the project of Jiangxi Provincial Administration of Traditional Chinese Medicine

Zitieren

APA

He, J., Luo, Y., Ding, Y., & Zhu, L. (2024). Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR ‐378a‐3p/ VEGFA / RGC ‐32 Axis. Cancer Medicine. https://doi.org/10.1002/cam4.70446

Vancouver

He J, Luo Y, Ding Y, Zhu L. Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR ‐378a‐3p/ VEGFA / RGC ‐32 Axis. Cancer Medicine. 2024. doi:10.1002/cam4.70446

BibTeX
@article{He2024,
  author = {He, Jinli and Luo, Yixing and Ding, Ying and Zhu, Liang},
  title = {Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR ‐378a‐3p/ VEGFA / RGC ‐32 Axis},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70446}
}
Kostenlos starten →